S&P 500
(-1.05%) 5 018.23 points
Dow Jones
(-1.44%) 37 908 points
Nasdaq
(-1.46%) 15 484 points
Oil
(-0.34%) $82.53
Gas
(-0.67%) $1.642
Gold
(0.20%) $2 343.10
Silver
(-0.08%) $27.33
Platinum
(0.47%) $920.15
USD/EUR
(-0.17%) $0.933
USD/NOK
(0.02%) $10.99
USD/GBP
(-0.22%) $0.801
USD/RUB
(-0.12%) $92.21

Realtime updates for Stayble Therapeutics AB [STABL.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated25 Apr 2024 @ 09:28

0.00% SEK 0.250

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 09:28):

Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain...

Stats
Today's Volume 30 495.00
Average Volume 181 830
Market Cap 7.91M
EPS SEK-0.222 ( 2023-09-30 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -0.250
ATR14 SEK0.00700 (2.81%)

Stayble Therapeutics AB Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Stayble Therapeutics AB Financials

Annual 2023
Revenue: SEK0
Gross Profit: SEK0 (0.00 %)
EPS: SEK-0.920
Q4 2023
Revenue: SEK0
Gross Profit: SEK0 (0.00 %)
EPS: SEK-0.200
Q3 2023
Revenue: SEK0
Gross Profit: SEK0 (0.00 %)
EPS: SEK-0.220
Q2 2023
Revenue: SEK0
Gross Profit: SEK0 (0.00 %)
EPS: SEK-0.260

Financial Reports:

No articles found.

Stayble Therapeutics AB

Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators